Inventor profile of:

Amit K. Jain

City:

Milpitas, California

Country:

United States

Published Applications:

37

Last publication date:

2026-05-28

Top Assignees for applications by Amit K. Jain

The entities that hold a legal rights for patent applications filed by inventor Jain Amit K.:

Recent patent applications by Jain Amit K.

Amit K. Jain from Milpitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28
US20260144762A1
Human necessities

TRANSDERMAL DELIVERY SYSTEM WITH A MICROPOROUS MEMBRANE HAVING SOLVENT-FILLED PORES

#2 | 2025-12-11
US20250375396A1
Human necessities

SODIUM BICARBONATE IN SITU CONVERSION DRIVEN TRANSDERMAL DELIVERY OF AMINE DRUG

#3 | 2025-12-11
US20250375395A1
Human necessities

TRANSDERMAL FORMULATION AND DELIVERY METHOD OF LOW SOLUBILITY OR UNSTABLE UNIONIZED NEUTRAL DRUGS BY IN SITU SALT-TO-NEUTRAL DRUG CONVERSION OF SALT DRUG

#4 | 2025-10-23
US20250325496A1
Human necessities

SODIUM BICARBONATE IN SITU CONVERSION DRIVEN TRANSDERMAL DELIVERY OF AMINE DRUG

#5 | 2024-05-16
US20240156747A1
Human necessities

METHODS FOR TREATING ALZHEIMER'S DISEASE WITH DONEPEZIL TRANSDERMAL SYSTEM

#6 | 2024-04-04
US20240108587A1
Human necessities

Systems comprising a composite backing and methods for long term transdermal administration

#7 | 2024-03-21
US20240091168A1
Human necessities

Systems and methods for long term transdermal administration

#8 | 2024-03-14
US20240082172A1
Human necessities

METHOD FOR DEPOT CREATION DURING TRANSDERMAL DRUG DELIVERY

#9 | 2024-02-08
US20240041791A1
Human necessities

TRANSDERMAL ADHESIVE COMPOSITION COMPRISING A POORLY SOLUBLE THERAPEUTIC AGENT

#10 | 2024-01-18
US20240016759A1
Human necessities

TRANSDERMAL DELIVERY SYSTEM WITH A MICROPOROUS MEMBRANE HAVING SOLVENT-FILLEDPORES

#11 | 2023-05-11
US20230145274A1
Human necessities

ADHESIVE MATRIX WITH HYDROPHILIC AND HYDROPHOBIC DOMAINS AND A THERAPEUTIC AGENT

#12 | 2023-03-23
US20230086303A1
Human necessities

Methods and compositions for treatment with donepezil

#13 | 2022-01-20
US20220016045A1
Human necessities

METHODS FOR TREATING ALZHEIMER'S DISEASE WITH DONEPEZIL TRANSDERMAL SYSTEM

#14 | 2021-07-01
US20210196650A1
Human necessities

Systems comprising a composite backing and methods for long term transdermal administration

#15 | 2021-01-28
US20210023020A1
Human necessities

Systems and methods for long term transdermal administration

#16 | 2021-01-21
US20210015761A1
Human necessities

SODIUM BICARBONATE IN SITU CONVERSION DRIVEN TRANSDERMAL DELIVERY OF AMINE DRUG

#17 | 2019-08-15
US20190247321A1
Human necessities

DONEPEZIL TRANSDERMAL DELIVERY SYSTEM

#18 | 2019-08-15
US20190247320A1
Human necessities

Methods for treating alzheimer's disease with donepezil transdermal system

#19 | 2019-08-01
US20190231709A1
Human necessities

Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent

#20 | 2019-06-20
US20190183810A1
Human necessities

Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

#21 | 2019-06-13
US20190175520A1
Human necessities

METHOD FOR DEPOT CREATION DURING TRANSDERMAL DRUG DELIVERY

#22 | 2019-01-31
US20190029971A1
Human necessities

TRANSDERMAL DELIVERY SYSTEM WITH A MICROPOROUS MEMBRANE HAVING SOLVENT-FILLED PORES

#23 | 2018-08-23
US20180235901A1
Human necessities

Donepezil transdermal delivery system

#24 | 2018-07-05
US20180185298A1
Human necessities

Transdermal Adhesive Composition Comprising A Poorly Soluble Therapeutic Agent

#25 | 2018-02-01
US20180028663A1
Human necessities

SODIUM BICARBONATE IN SITU CONVERSION DRIVEN TRANSDERMAL DELIVERY OF AMINE DRUG

#26 | 2018-02-01
US20180028512A1
Human necessities

Donepezil transdermal delivery system

#27 | 2018-02-01
US20180028467A1
Human necessities

Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery

#28 | 2018-02-01
US20180028466A1
Human necessities

Memantine transdermal delivery systems

#29 | 2018-02-01
US20180028463A1
Human necessities

TRANSDERMAL FORMULATION AND DELIVERY METHOD OF LOW SOLUBILITY OR UNSTABLE UNIONIZED NEUTRAL DRUGS BY IN SITU SALT-TO-NEUTRAL DRUG CONVERSION OF SALT DRUG

#30 | 2018-02-01
US20180028462A1
Human necessities

Donepezil transdermal delivery system

#31 | 2018-02-01
US20180028461A1
Human necessities

TRANSDERMAL DELIVERY SYSTEMS WITH PHARMACOKINETICS BIOEQUIVALENT TO ORAL DELIVERY

#32 | 2017-07-06
US20170189534A1
Human necessities

Systems comprising a composite backing and methods for long term transdermal administration

#33 | 2017-07-06
US20170189348A1
Human necessities

Systems and methods for long term transdermal administration

#34 | 2017-06-15
US20170165212A1
Human necessities

Transdermal administration of tamsulosin

#35 | 2016-12-08
US20160354369A1
Human necessities

Formulations for aripiprazole delivery transdermally

#36 | 2014-10-30
US20140322284A1
Human necessities

Transdermal administration of tamsulosin

#37 | 2010-11-18
US20100291186A1
Human necessities

Transdermal administration of tamsulosin

InventorID:

952830 ⎘